Pathology teach and tell: Pediatric gastrointestinal stromal tumor

Pediatric Pathology and Molecular Medicine

Volumn 22, Issue 3, 2003, Pages 259-264

  Sebire, N J ^a   Ramsay, A ^a   Malone, M ^a   Risdon, R ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; GASTROINTESTINAL STROMAL TUMOR; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL;

ADOLESCENT; ANTIGENS, CD34; DISEASE-FREE SURVIVAL; HUMANS; MALE; MESENCHYMOMA; PROTO-ONCOGENE PROTEINS C-KIT; STOMACH NEOPLASMS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038636376     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/15227950307738     Document Type: Article

References (27)

1. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11(8):728-734.
2. Miettinen M, Lasota J. Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438(1):1-12.
3. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999;23(4):377-389.
4. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol 2000;13(10):1134-1142.
5. Lee, JR, Joshi V, Griffin, JW Jr, Lasota J, Miettinen M. Gastrointestinal autonomic nerve tumor: Immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol 2001;25(8):979-987.
6. Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999;23(9):1109-1118.
7. Graadt van Roggen JF, van Velthuysen ML, Hogendoorn PC. The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 2001;54(2):96-102.
8. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: Recent advances in understanding of their biology. Hum Pathol 1999;30(10):1213-1220.
9. Fukada R. Gastrointestinal stromal tumor with a novel mutation of KIT proto-oncogene. Intern Med 2001;40(4):301-303.
10. Hirota S, Nishida T, Isozaki K, Taniguchi M, Nakamura J, Okazaki T, et al. Gainof-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours. J Pathol 2001;193(4):505-510.
11. Longley BJ, Reguera MJ, Ma Y. Classes of c-KIT activating mutations: Proposed mechanisms of action and implications for disease classification and therapy. Leuk Res 2001;25(7):571-576.
12. Nakahara M, Isozaki K, Hirota S, Miyagawa J, Hase-Sawada N, Taniguchi M, et al. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology 1998;115(5):1090-1095.
13. Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M. C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal. Jpn J Cancer Res 1999;90(12):1321-1328.
14. Sakurai S, Oguni S, Hironaka M, Fukayama M, Morinaga S, Saito K. Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese. Jpn J Cancer Res 2001;92(5):494-498.
15. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999;154(1):53-60.
16. Nishida T, Nakamura J, Taniguchi M, Hirota S, Ito T, Kitamura Y, et al. Clinicopathological features of gastric stromal tumors. J Exp Clin Cancer Res 2000;19(4):417-425.
17. Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 1999;59(17):4297-4300.
18. Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 2001;61(22):8118-8121.
19. Beghini A, Tibiletti MG, Roversi G, Chiaravalli AM, Serio G, Capella C, et al. Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 2001;92(3):657-662.
20. Maeyama H, Hidaka E, Ota H, Minami S, Kajiyama M, Kuraishi A, et al. Familial gastrointestinal stromal tumor with hyperpigmentation: Association with a germline mutation of the c-kit gene. Gastroenterology 2001;120(1):210-215.
21. Breiner JA, Meis-Kindblom J, Kindblom LG, McComb E, Liu J, Nelson M, et al. Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). Cancer Genet Cytogenet 2000;120(2):111-116.
22. Fukasawa T, Chong JM, Sakurai S, Koshiishi N, Ikeno R, Tanaka A, et al. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor. Jpn J Cancer Res 2000;91(12):1241-1249.
23. Miettinen M. Are desmoid tumors KIT positive? Am J Surg Pathol 2001;25(4):549-550.
24. Yantiss RK, Rosenberg AE. Are desmoid tumors KIT positive? Am J Surg Pathol 2001;25(4):550.
25. Yantiss RK, Spiro IJ, Compton CC, Rosenberg AE. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: A clinically important differential diagnosis. Am J Surg Pathol 2000;24(7):947-957.
26. Bates AW, Feakins RM, Scheimberg I. Congenital gastrointestinal stromal tumour is morphologically indistinguishable from the adult form, but does not express CD117 and carries a favourable prognosis. Histopathology 2000;37(4):316-322.
27. Berman J, O'Leary TJ. Gastrointestinal stromal tumor workshop. Hum Pathol 2001;32(6):578-582.